| Article | Date | Source |
|---|
| CBPartners Runs ISPOR Workshop Evaluating Orphan and Ultra-Orphan HTA... | -- | PRWeb - Pharmaceuticals |
| IRS Draft Rule Defines Orphan Drugs in Context of ACA Tax | -- | Pharmaceutical - Moreover |
| XOMA Antibody Receives Orphan Drug Designation from the FDA and EMA | -- | Outsourcing - BioPharm |
| Orphan drug workshops | -- | Nature Biotechnology |
| Charmed by orphan drugs, suitors line up for ViroPharma | June 18, 2013 | FiercePharma |
| ViroPharma drug gets orphan designation | June 11, 2013 | Health News - BizJournals.com |
| Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Head and Neck Cancer with ADXS-HPV | June 11, 2013 | FDA News - Business Wire |
| ViroPharma Receives Orphan Drug Designation For Maribavir In Europe | June 11, 2013 | Pharma News - PR Newswire |
| Advaxis, Inc. Requests Orphan Drug Designation for Treatment of Cervical Cancer With ADXS-HPV | June 07, 2013 | BioSpace - Breaking News |
| Advaxis Requests Orphan Drug Designation for Treatment of Cervical Cancer with ADXS-HPV | June 07, 2013 | FDA News - Business Wire |
| OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria | June 04, 2013 | Biotech News - PR Newswire |
| Jennerex, Inc. Granted FDA Orphan Drug Designation for Pexa-Vec in Hepatocellular Carcinoma (HCC) | May 09, 2013 | BioSpace - Breaking News |
| EU-Zulassungsbehörden erteilen Lenvatinib von Eisai "Orphan Drug"-Status für die Behandlung von radiojod-refraktären differenzierten Schilddrüsenkarzinomen | May 06, 2013 | Biotech News - PR Newswire |
| Raptor's orphan drug-win at FDA overshadowed by debate over steep price | May 01, 2013 | FierceBiotech |
| Worldwide Orphan Drug Market to Grow to $127 Billion by 2018 | April 23, 2013 | Biotech News - Business Wire |
| Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402 | April 23, 2013 | Pharma News - Business Wire |
| Worldwide Orphan Drug Market to Grow to $127 Billion by 2018 | April 23, 2013 | Pharma News - Business Wire |
| Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402 | April 23, 2013 | FDA News - Business Wire |
| Evaluate to Launch Orphan Drug Report at the 2013 BIO International Convention | April 12, 2013 | Pharma News - PharmiWeb |
| <b>Evaluate</b> to Launch Orphan Drug Report at the 2013 Biotechnology Industry Organization (BIO) International Convention
| April 12, 2013 | BioSpace - Breaking News |
| Evaluate to Launch Orphan Drug Report at the 2013 BIO International Convention | April 12, 2013 | Biotech News - Business Wire |
| Evaluate to Launch Orphan Drug Report at the 2013 BIO International Convention | April 12, 2013 | Pharma News - Business Wire |
| Rare, orphan drug accelerator launches in Cambridge with $16M | April 11, 2013 | Health News - BizJournals.com |
| NEA leads $16m investment in orphan drug accelerator | April 11, 2013 | Health News - BizJournals.com |
| Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate Equities | April 11, 2013 | Biotech News - Business Wire |
| Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate Equities | April 11, 2013 | Pharma News - Business Wire |
| Acceleron receives two orphan drug designations from FDA | March 27, 2013 | Health News - BizJournals.com |
| Acceleron wins orphan status for ACE-536 | March 27, 2013 | FierceBiotech |
| Acceleron Receives Two FDA Orphan Designations for ACE-536 | March 26, 2013 | Biotech News - Business Wire |
| Acceleron Receives Two FDA Orphan Designations for ACE-536 | March 26, 2013 | Pharma News - Business Wire |
| Acceleron Receives Two FDA Orphan Designations for ACE-536 | March 26, 2013 | FDA News - Business Wire |
| GenSpera receives orphan drug designation from FDA for treatment of carcinoma | March 14, 2013 | Health News - BizJournals.com |
| GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular Carcinoma | March 14, 2013 | Pharma News - PharmiWeb |
| GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular Carcinoma | March 14, 2013 | Pharma News - Business Wire |
| GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular Carcinoma | March 14, 2013 | FDA News - Business Wire |
| Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential | March 04, 2013 | Biotech News - PR Newswire |
| Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan Disease | February 26, 2013 | Pharma News - PharmiWeb |
| Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan Disease | February 26, 2013 | Clinical Trials - Business Wire |
| Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan Disease | February 26, 2013 | Biotech News - Business Wire |
| Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan Disease | February 26, 2013 | Pharma News - Business Wire |
| Research and Markets: Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need | February 04, 2013 | Pharma News - Business Wire |
| Inherited Orphan Blood Disorders Therapeutics Market Examined in New GBI Research Report Recently Published at MarketPublishers.com | January 29, 2013 | Pharma News - PharmiWeb |
| Inherited Orphan Blood Disorders Therapeutics Market Examined in New GBI Research Report Recently Published at MarketPublishers.com | January 29, 2013 | Biotech News - Business Wire |
| Inherited Orphan Blood Disorders Therapeutics Market Examined in New GBI Research Report Recently Published at MarketPublishers.com | January 29, 2013 | Pharma News - Business Wire |
| Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need | January 29, 2013 | Pharma News - PR Newswire |
| Research and Markets: Orphan Drugs: Market Environment Products and Companies | January 16, 2013 | Pharma News - PharmiWeb |
| Research and Markets: Orphan Drugs: Market Environment Products and Companies | January 16, 2013 | Pharma News - Business Wire |
| Telik Announces Orphan Designation Of Telintra® For Treatment Of Myelodysplastic Syndrome | January 12, 2013 | Biotech News - PR Newswire |
| <b>Proteo, Inc. / Proteo Biotech AG</b>: FDA Grants <b>Proteo</b> Orphan Drug Designation to Elafin for the Treatment of Pulmonary Arterial Hypertension | January 10, 2013 | BioSpace - Breaking News |
| Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertension | January 10, 2013 | Pharma News - PharmiWeb |
| Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertension | January 10, 2013 | Clinical Trials - Business Wire |
| Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertension | January 10, 2013 | Biotech News - Business Wire |
| Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertension | January 10, 2013 | Pharma News - Business Wire |
| Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertension | January 10, 2013 | FDA News - Business Wire |
| FDA Approves Swedish Orphan Biovitrum's Kineret for the Treatment of NOMID | January 08, 2013 | BioSpace - Breaking News |
| Shire gambles on one-man biotech startup to gain ultra-orphan drug | January 08, 2013 | FierceBiotech |
| FDA advisers back NPS Pharma's orphan bowel drug | October 16, 2012 | FierceBiotech |
| Research and Markets: Raptor's RP 103 for Nephropathic Cystinosis - an Orphan Genetic Disease | October 15, 2012 | Pharma News - Business Wire |
| Cell Therapeutics rises on orphan drug decision | October 02, 2012 | Health News - CNBC |
| Endocyte, Inc. Granted Orphan Drug Status for Folic Acid by European Commission (EC) | September 27, 2012 | BioSpace - Breaking News |
| Depomed sues FDA over 'additional hurdles' to orphan exclusivity | September 27, 2012 | FiercePharma |
| Depomed Files Suit Against The FDA Seeking Grant Of Orphan Drug Exclusivity For Gralise® (Gabapentin) | September 25, 2012 | Pharma News - PR Newswire |
| Omeros Awarded NIMH Grant for Development of Orphan GPCR Antibodies | September 19, 2012 | Medical Pharma - PR Newswire |
| EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome | September 12, 2012 | Pharma News - PR Newswire |
| Cerus to Partner with American Red Cross and Blood Systems Incorporated to Commercialize INTERCEPT Plasma for Thrombotic Thrombocytopenic Purpura (TTP) Orphan Indication | September 11, 2012 | FDA News - Business Wire |
| UPDATED: Pfizer wins FDA approval for orphan chronic myelogenous leukemia drug | September 04, 2012 | FierceBiotech |
| FDA approves new orphan drug for chronic myelogenous leukemia | September 04, 2012 | FDA Press Releases |
| Aerial BioPharma Receives FDA Orphan Drug Designation for Narcolepsy Drug in Development | August 29, 2012 | Pharma News - Business Wire |
| Pharmalucence, Inc. Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients | August 16, 2012 | BioSpace |
| Pharmalucence Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients | August 16, 2012 | FDA News - Business Wire |
| Omeros Has Now Unlocked Over Half of the Class A Orphan GPCRs | August 15, 2012 | Biotech News - PR Newswire |
| Senesco’s Lead Therapeutic Candidate, SNS01-T, Granted Orphan Drug Status from FDA for Treatment of Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma | July 30, 2012 | Pharma News - Business Wire |
| Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma | July 24, 2012 | b3c newswire |
| Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases | July 24, 2012 | Biotech News - PR Newswire |
| PTC investors back lead orphan drug with $30M round | July 23, 2012 | FierceBiotech |
| Hemispherx seeks orphan status in Argentina for chronic fatigue drug | July 18, 2012 | Health News - BizJournals.com |
| <b>European Commission</b> Grants Orphan Medicinal Product Designation for Emmaus Medical, Inc.'s Sickle Cell Treatment | July 17, 2012 | BioSpace - Breaking News |
| Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis | July 17, 2012 | Pharma News - PR Newswire |
| European Commission Grants Orphan Medicinal Product Designation for Emmaus Medical's Sickle Cell Treatment | July 17, 2012 | Pharma News - PharmiWeb |
| Swedish Orphan Biovitrum Enters Research Collaboration With Affibody Within the IL-1 Field | July 10, 2012 | BioSpace - Breaking News |
| Cytheris SA Announces CYT107 Orphan Drug Designation in Europe for the Treatment of Progressive Multifocal Leucoencephalopathy (PML) | July 10, 2012 | BioSpace - Breaking News |
| Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington's Disease Segment | June 28, 2012 | Medical Pharma - PR Newswire |
| Research and Markets: Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making | June 27, 2012 | Pharma News - Business Wire |
| Medgenics Receives Orphan Drug Designation from FDA for INFRADURE Biopump to Treat Hepatitis D | June 20, 2012 | FDA News - Business Wire |
| Alnylam Pharmaceuticals Gets Orphan Status for Neurodegenerative Disease Drug | June 20, 2012 | BioSpace |
| Stratatech’s StrataGraft® Skin Substitute Granted FDA Orphan Drug Designation | June 13, 2012 | FDA News - Business Wire |
| ERYTECH Pharma’s Sickle Cell Treatment Receives Positive Opinion for Orphan Drug Designation from the European Medicines Agency | June 13, 2012 | Pharma News - Business Wire |
| FDA Issues Orphan Status Approval for PermaDerm® | June 12, 2012 | Biotech News - PR Newswire |
| NORD Calls Senate Bill Most Important Since Orphan Drug Act | May 24, 2012 | Pharma News - PR Newswire |
| Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity | May 23, 2012 | Medical Pharma - PR Newswire |
| Research and Markets: Orphan Disease Therapeutics Market to 2018 - Big Pharma to Target Orphan Diseases | May 22, 2012 | Pharma News - Business Wire |
| Market Research Forecasts Oncology Orphan Disease Market at $6.4 Billion by 2018 | May 22, 2012 | Marketwire - Pharma and Biotech |
| Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases% Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation | May 10, 2012 | Medical Pharma - PR Newswire |
| Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules | May 10, 2012 | Medical Pharma - PR Newswire |
| Medgenics Files for U.S. Orphan Drug Designation for INFRADURE for the Treatment of Hepatitis D | April 23, 2012 | FDA News - Business Wire |
| BioAlliance Pharma Announces: New Achievements in Clonidine Lauriad™ Clinical Development, Second Product of Its Orphan Oncology Portfolio | April 17, 2012 | Pharma News - Business Wire |
| REGENX Biosciences, LLC Receives FDA Orphan Designation for Treatment of Familial Hypercholesterolemia Using NAV(TM) rAAV8 Vectors | April 10, 2012 | BioSpace - Breaking News |
| REGENX BioSciences Receives FDA Orphan Designation for Treatment of Familial Hypercholesterolemia Using NAV(TM) rAAV8 Vectors | April 10, 2012 | Marketwire - Pharma and Biotech |
| FDA gives Threshold's TH-302 orphan drug status | March 30, 2012 | Health News - CNBC |
| Swedish Orphan Biovitrum Amends its Agreement With Sellers of Arexis AB | March 30, 2012 | BioSpace - Breaking News |
| Threshold Pharmaceuticals, Inc.'s Cancer Drug Gets FDA Orphan Status, Shares Rise | March 30, 2012 | BioSpace |
| Threshold cancer drug gets orphan status in U.S. | March 30, 2012 | Health News - CNBC |
| Threshold's cancer drug gets FDA orphan status, shares rise | March 30, 2012 | Health News - CNBC |
| Threshold Pharmaceuticals Receives US Orphan Drug Designation for TH-302 for the Treatment of Soft Tissue Sarcoma | March 30, 2012 | Marketwire - Pharma and Biotech |
| FDA Grants Orphan Status to Lexicon Pharmaceuticals, Inc. Cancer Drug | March 21, 2012 | BioSpace - Breaking News |
| FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome | March 20, 2012 | Biotech News - PR Newswire |
| Threshold Pharmaceuticals, Inc.' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma | March 16, 2012 | BioSpace - Breaking News |
| Threshold Pharmaceuticals' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma | March 16, 2012 | Marketwire - Pharma and Biotech |
| Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) | March 07, 2012 | FDA News - Business Wire |
| 4s3 Raises $20M to Create Protein Therapies for Orphan Neuromuscular Disorders | March 06, 2012 | Inside Industry - Gen |
| Cytokinetics, Inc. Announces That the European Medicines Evaluation Agency Has Granted CK-2017357 Orphan Medicinal Product Designation for the Treatment of Amyotrophic Lateral Sclerosis | March 06, 2012 | BioSpace - Breaking News |
| Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement to Develop and Commercialize Deuterium-modified Dextromethorphan for Disorders of the Nervous System | February 29, 2012 | Biotech News - PR Newswire |
| Adding Six More, Omeros Now Has a Total of 33 Unlocked Orphan GPCRs in its Portfolio | February 29, 2012 | Medical Pharma - PR Newswire |
| Ultragenyx lands orphan designation for 2nd drug | February 28, 2012 | Health News - BizJournals.com |
| FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma | February 23, 2012 | FDA News - Business Wire |
| Omeros Announces It Has Unlocked 35 Percent of Class A Orphan GPCRs | February 23, 2012 | Biotech News - PR Newswire |
| Syria's 'orphan revolution' | February 20, 2012 | CNN Top Stories |
| CSL hemophilia treatment gets orphan drug status in U.S. | February 16, 2012 | Health News - BizJournals.com |
| ReFacto AF(R)/XYNTHA(R) Supply Agreement Extended Until 2020 for Swedish Orphan Biovitrum and Pfizer Inc. | February 16, 2012 | BioSpace - Breaking News |
| CSL Behring Receives FDA Orphan Drug Designation for rVIIa-FP, a Novel Therapy in Development to Treat Hemophilia A and Hemophilia B Patients Who Have Inhibitors | February 16, 2012 | Pharma News - PR Newswire |
| Nationally Recognized Glenveigh Medical Announces Orphan Drug Designation for Treatment for Severe Preeclampsia and Eclampsia | February 14, 2012 | Pharma News - PR Newswire |
| Swedish Orphan Biovitrum's Agreement With Biogen Idec, Inc. (Massachusetts) Regarding Long-Lasting rFVIIIFc and rFIXFc Hemophilia Programs | February 06, 2012 | BioSpace |
| BioLife Solutions Congratulates DCPrime on Its Approved Orphan Medicinal Product Application for DCOne™ Leukemia Vaccine | February 06, 2012 | Pharma News - PR Newswire |
| Del Mar Pharmaceuticals Granted U.S. Orphan Drug Designation for VAL-083 for the Treatment of Glioma | February 02, 2012 | Marketwire - Pharma and Biotech |
| European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's Acute Myeloid Leukemia Vaccine | February 01, 2012 | Pharma News - PharmiWeb |
| European Medicines Evaluation Agency Approves Orphan Medicinal Product Application of Acute Myeloid Leukemia Vaccine | February 01, 2012 | BioSpace - Breaking News |
| BioMarin aims to scoop up rare disease drugs as orphan field sizzles | January 27, 2012 | FierceBiotech |
| Celator Pharmaceuticals, Inc. Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia | January 26, 2012 | BioSpace - Breaking News |
| Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia | January 26, 2012 | FDA News - Business Wire |
| FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension | January 23, 2012 | Pharma News - PR Newswire |
| Research and Markets: Orphan Drug Report 2012 Profiles the Pharmaceutical Drugs with Orphan Drug Exclusivity Granted by the FDA (BIZ) | January 19, 2012 | Pharmaceutical - Moreover |
| Research and Markets: Orphan Drug Report 2012 Profiles the Pharmaceutical... | January 19, 2012 | Pharmaceutical - Moreover |
| Research and Markets: Orphan Drug Report 2012 Profiles the Pharmaceutical Drugs with Orphan Drug Exclusivity Granted by the FDA | January 19, 2012 | FDA News - Business Wire |
| Ceptaris cutaneous T-cell lymphoma drug gets Europe orphan status | January 18, 2012 | Health News - BizJournals.com |
| Ceptaris Therapeutics, Inc. Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel | January 18, 2012 | BioSpace - Breaking News |
| Orphan Drug Markets in Europe: Key Developments and the Strategies of Major Pharmaceutical Companies | January 18, 2012 | Pharmaceutical - Moreover |
| Ceptaris Therapeutics Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel | January 18, 2012 | Pharma News - Business Wire |
| Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs | January 10, 2012 | Biotech News - PR Newswire |
| AiCuris Receives Orphan Drug Designation for Letermovir (AIC246) from FDA | January 05, 2012 | b3c newswire |
| EMA Grants Orphan Drug Status to NovaBiotics Lynovex | January 05, 2012 | Biotechnology - Moreover |
| Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy | January 04, 2012 | Biotech News - PR Newswire |
| FDA Grants Orphan Drug Status to Spectrum Pharmaceuticals' Fusilev [Health & Beauty Close - Up] | December 14, 2011 | Biotechnology - Moreover |
| Treatment of Patients With Malignant Mesothelioma Utilizing Photodynamic Therapy With Pinnacle Biologics' Compound PHOTOFRIN® - Obtains FDA Orphan Drug Designation | December 14, 2011 | Biotech News - PR Newswire |
| Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer | December 12, 2011 | Biotech News - PR Newswire |
| Number of Orphan Medicines to Grow in Europe as 'Big Pharma' Takes an Interest Says New Report from URCH Publishing | December 09, 2011 | Pharmaceutical - Moreover |
| Number of Orphan Medicines to Grow in Europe as ‘Big Pharma’ Takes an Interest Says New Report from URCH Publishing | December 09, 2011 | Pharma News - Business Wire |
| S.L.A. Pharma Announce Phase III Orphan Drug Program for FAP | December 08, 2011 | Pharma News - PharmiWeb |
| Avedro Announces Its Second FDA Orphan Drug Designation for Corneal Cross-linking | December 07, 2011 | FDA News - Business Wire |
| Médunik Canada to help Canadians with rare diseases with two new orphan therapies | November 29, 2011 | Pharmaceutical - Moreover |
| Mdunik Canada to help Canadians with rare diseases with two new orphan therapies | November 29, 2011 | Pharmaceutical - Moreover |
| M�dunik Canada to help Canadians with rare diseases with two new orphan therapies (CNW) | November 29, 2011 | Pharmaceutical - Moreover |
| Médunik Canada to help Canadians with rare diseases with two new orphan therapies | November 29, 2011 | Biotech News - PR Newswire |
| Hanmi applies for orphan drug designation for LAPS-rhGH | November 28, 2011 | Pharmaceutical - Moreover |
| Research and Markets: Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology | November 14, 2011 | Clinical Trials - Business Wire |
| Santen Announces FDA Orphan Drug Status for Sirolimus (DE-109) | November 10, 2011 | Pharma News - Business Wire |
| DuoCort Pharma's Orphan Drug Plenadren® Granted European Marketing Authorization for Adrenal Insufficiency | November 07, 2011 | Pharma News - PR Newswire |
| Genome of 'orphan crop' pigeonpea cracked | November 07, 2011 | Biotechnology - Moreover |
| BioAlliance Pharma Announces: Grant of Orphan Designation for clonidine Lauriad??? in Europe | November 03, 2011 | BioSpace - Breaking News |
| Clinuvel Announces Positive Results of First Phase II US Study of SCENESSE?? in Orphan Disease erythropoietic protoporphyria (EPP)
| November 03, 2011 | BioSpace - Breaking News |
| Discovery Lab’s cystic fibrosis treatment gets Europe orphan status | November 03, 2011 | Health News - BizJournals.com |
| Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria (EPP) | November 03, 2011 | Pharma News - Business Wire |
| Biotechnology Industry Organization (BIO) Announces: Grant of Orphan Designation for Clonidine Lauriad(TM) in Europe | November 02, 2011 | Biotechnology - Moreover |
| Celldex Therapeutics, Inc. Announces Orphan Drug Designation in the European Union for Rindopepimut, a Novel EGFRvIII Vaccine for Glioblastoma | October 31, 2011 | BioSpace - Breaking News |
| Celldex Therapeutics Announces Orphan Drug Designation in the European Union for Rindopepimut, a Novel EGFRvIII Vaccine for Glioblastoma | October 31, 2011 | FDA News - Business Wire |
| ViroPharma inks $164M deal to buy orphan drug biotech | October 27, 2011 | FierceBiotech |
| ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline | October 27, 2011 | Biotech News - PR Newswire |
| Atox Bio Granted Orphan Drug Designation for AB103 for the Treatment of Necrotizing Soft Tissue Infections (NSTI). | October 25, 2011 | FDA News - Business Wire |
| Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. | October 24, 2011 | Biotech News - PR Newswire |
| Swedish Orphan Biovitrum AB (publ): Interim Report January - September, 2011 | October 20, 2011 | Marketwire - Pharma and Biotech |
| 4SC AG's Anti-Cancer Compound Resminostat Receives Positive Opinion for Orphan Medicinal Product Designation in Europe to Treat Hodgkin's Lymphoma | October 13, 2011 | BioSpace - Breaking News |
| 4SC's Anti-Cancer Compound Resminostat Receives Positive Opinion for Orphan Medicinal Product Designation in Europe to Treat Hodgkin's Lymphoma | October 13, 2011 | Pharma News - Business Wire |
| 4SCs Anti-Tumor-Wirkstoff Resminostat erhält in Indikation Hodgkin Lymphom Empfehlung zur Einstufung als 'Orphan Medicinal Product' in Europa | October 13, 2011 | Pharma News - Business Wire |
| Orphan Drug Specialist | October 12, 2011 | Pharmaceutical - Moreover |
| Study: Orphan drugs win favored status in FDA reviews | October 12, 2011 | FierceBiotech |
| OctreoPharm Sciences Receives Orphan Drug Designation for SOMscan® for the Diagnosis of Neuroendocrine Tumours | October 12, 2011 | Biotech News - PR Newswire |
| Cost of orphan drugs to EU 'sustainable until 2020' Friday 7th October 2011 | October 11, 2011 | Pharmaceutical - Moreover |
| Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body Myopathy | October 08, 2011 | Pharmaceutical - Moreover |
| Orphan drugs cost likely to be sustainable to European health budgets in the next 10 years, new research shows | October 07, 2011 | Pharmaceutical - Moreover |
| Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body Myopathy (HIBM) | October 05, 2011 | Biotech News - PR Newswire |
| Head of R&D to leave Swedish Orphan Biovitrum | October 04, 2011 | BioSpace - Breaking News |
| Tarix Pharmaceuticals' TXA127 Granted Orphan Drug Status for Treatment of Pulmonary Arterial Hypertension | September 27, 2011 | BioSpace - Breaking News |
| Aeolus files Orphan Drug Designation application for AEOL 10150 | September 26, 2011 | Biotechnology - Moreover |
| 4SC's Resminostat receives FDA Orphan Drug Status for Hodgkin's Lymphoma | September 26, 2011 | Pharma News - Business Wire |
| Aeolus Pharma Files Request For Orphan Drug Designation Of AEOL 10150 | September 23, 2011 | Biotechnology - Moreover |
| Aeolus Pharmaceuticals Files Request for Orphan Drug Designation of AEOL 10150 for Mitigation, and/or Treatment of Delayed Effects of Acute Radiation Exposure of the Lung | September 23, 2011 | Marketwire - Pharma and Biotech |
| Dove Medical Press Announces Dr Lise Aagaard as the Editor-in-Chief of Orphan Drugs: Research and Reviews | September 21, 2011 | Pharmaceutical - Moreover |
| DIA/FDA Orphan Drug Designation One-Day Workshop | September 20, 2011 | Biotechnology - Moreover |
| DIA and NORD Host First Conference to Address All Aspects of Orphan Product Development | September 15, 2011 | Biotechnology - Moreover |
| CEL-SCI’s Taiwanese Partner Orient Europharma Presents Development Strategies in Taiwan for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection) at World Orphan Drug Conference Today in Seoul, Korea | September 15, 2011 | Biotech News - Business Wire |
| NORD and DIA to Host Conference on Rare Diseases and Orphan Products | September 14, 2011 | Pharma News - PR Newswire |
| Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Prevention of Graft-Versus-Host Disease in Bone Marrow Transplant | September 14, 2011 | BioSpace - Breaking News |
| Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune™ Therapy for the Prevention of Graft-Versus-Host Disease in Bone Marrow Transplant | September 14, 2011 | FDA News - Business Wire |
| Omeros announces unlocking four additional Orphan GPCRs | September 14, 2011 | Pharmaceutical - Moreover |
| Uveitis drug granted EU orphan status | September 14, 2011 | Pharmaceutical - Moreover |
| Centric Health Resources Annual Conference Addresses Concerns of Ultra Orphan Patient Populations Speakers include Kenneth J. Tomaszewski, KJT Group; Michael McCaughan, Prevision Policy, LLC; Molly Stuart, International Pemphigus and Pemphigoid Foundatio | September 13, 2011 | Pharmaceutical - Moreover |
| Centric Health Resources Annual Conference Addresses Concerns of Ultra Orphan Patient Populations | September 13, 2011 | Pharma News - Business Wire |
| Omeros Unlocks Four Additional Orphan GPCRs | September 13, 2011 | Biotech News - PR Newswire |
| Avedro VibeX gets FDA orphan drug status | September 13, 2011 | Pharmaceutical - Moreover |
| Avedro, Inc. Announces FDA Orphan Drug Designation for Its Corneal Cross-linking | September 12, 2011 | BioSpace - Breaking News |
| Avedro Announces FDA Orphan Drug Designation for Its Corneal Cross-linking | September 12, 2011 | FDA News - Business Wire |
| DIA / FDA Orphan Drug Designation Workshop | September 10, 2011 | Biotechnology - Moreover |
| Santen, Inc. Announces European Medicines Evaluation Agency Orphan Drug Status for Sirolimus (DE-109) | September 08, 2011 | BioSpace - Breaking News |
| EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis | September 08, 2011 | Pharmaceutical - Moreover |
| Santen sirolimus gets EC orphan drug status | September 08, 2011 | Pharmaceutical - Moreover |
| Santen Announces EMA Orphan Drug Status for Sirolimus (DE-109) | September 08, 2011 | Pharma News - Business Wire |
| OPKO Health Announces Grant from Penn Center for Orphan Disease Research and Therapy | September 06, 2011 | Biotech News - Business Wire |
| Mitsubishi Tanabe Pharma taps Synageva for orphan disease R&D | September 02, 2011 | FierceBiotech |
| NPS Re-Jiggers Glaxo Partnership, Finds Value in Ultra-Orphan Diseases | August 09, 2011 | Xconomy Life Sciences |
| US Conference on Rare Diseases and Orphan Products | August 08, 2011 | Biotechnology - Moreover |
| Kamada Ltd. Was Granted New Orphan Drug Designation by the FDA for the Treatment of Type 1 Diabetes | August 04, 2011 | BioSpace - Breaking News |
| Kamada Ltd. Was Granted New Orphan Drug Designation by the FDA, for the Treatment of Type 1 Diabetes | August 04, 2011 | BioSpace - Breaking News |
| Kamada Was Granted New Orphan Drug Designation by the FDA, for the Treatment of Type 1 Diabetes | August 04, 2011 | Pharma News - Business Wire |
| Swedish Orphan Biovitrum Release: First Patient Enrolled in the Kiobrina(R) Phase III Study | August 02, 2011 | BioSpace - Breaking News |
| FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals' MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer | August 01, 2011 | Biotech News - PR Newswire |
| Q2 2011: BioAlliance Pharma Accelerates the Progress of Its “Orphan Oncology Products” Portfolio and Pursues Its International Partnerships on Its “Specialty Products” | July 28, 2011 | Pharma News - Business Wire |
| Penn erhält $10 Millionen zur Gründung eines Forschung- und Therapiezentrums für Orphan Diseases | July 27, 2011 | Biotech News - PR Newswire |
| Penn medical school to create orphan drug center with $10M gift | July 26, 2011 | Health News - BizJournals.com |
| Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy | July 26, 2011 | Biotech News - PR Newswire |
| Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis Meeting | July 26, 2011 | BioSpace - Breaking News |
| Biogen Idec, Inc. (California) and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at Meeting | July 26, 2011 | BioSpace - Breaking News |
| FDA Grants s TM-400 Orphan Drug Designation for Mobilization of Stem Cells Used to Treat Hematologic Cancer in the U.S. | July 26, 2011 | BioSpace - Breaking News |
| Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer | July 26, 2011 | FDA News - Business Wire |
| Samenvatting: Biogen Idec en Swedish Orphan Biovitrum presenteren gegevens van behandeling met langdurig werkzame recombinante factor VIII tijdens bijeenkomst van internationale vereniging voor trombose en hemostase | July 26, 2011 | Pharma News - Business Wire |
| Resumen: Biogen Idec y Swedish Orphan Biovitrum presentan datos sobre tratamiento del factor VIII recombinante con acción duradera en la reunión de la International Society sobre trombosis y hemostasia | July 26, 2011 | Pharma News - Business Wire |
| Biogen Idec und Swedish Orphan Biovitrum legen Daten zur Therapie mit dem langwirkenden rekombinanten Faktor VIII auf der Tagung der International Society on Thrombosis and Haemostasis vor | July 26, 2011 | Pharma News - Business Wire |
| Biogen Idec et Swedish Orphan Biovitrum présentent des résultats sur le traitement avec le facteur VIII recombinant à action prolongée à l'occasion de la réunion de la Société internationale de thrombose et d'hémostase | July 26, 2011 | Pharma News - Business Wire |
| FDA Grants TM-400 Orphan Drug Designation for Mobilization of Stem Cells Used to Treat Hematologic Cancer in the U.S. | July 26, 2011 | FDA News - Business Wire |
| European Medicines Agency Adopts Positive Opinion for Orphan Medicinal Product Designation for 4SC's Resminostat to Treat Hepatocellular Carcinoma | July 26, 2011 | Pharma News - Business Wire |
| Europäische Arzneimittelagentur EMA empfiehlt Einstufung des 4SC-Wirkstoffs Resminostat als 'Orphan Medicinal Product' zur Behandlung des hepatozellulären Karzinoms | July 26, 2011 | Pharma News - Business Wire |
| Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis Meeting | July 26, 2011 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Swedish Orphan Biovitrum presentano dati sulla terapia di lunga durata con fattore VIII ricombinante alla riunione dell'International Society on Thrombosis and Haemostasis | July 26, 2011 | Pharma News - Business Wire |
| FDA's Coté, Director Of Orphan Products Development Office, Jumps To NORD | July 20, 2011 | Pharmaceutical - Moreover |
| Swedish Orphan Biovitrum: Interim Report January - June 2011 | July 19, 2011 | Marketwire - Pharma and Biotech |
| Notice at extraordinary general meeting in Swedish Orphan Biovitrum AB (publ) | July 19, 2011 | Marketwire - Pharma and Biotech |
| Nektar Therapeutics (CA)'s NKTR-102 Receives Positive Opinion From European Medicines Evaluation Agency COMP for Orphan Medicinal Product Designation in Ovarian Cancer | July 18, 2011 | BioSpace - Breaking News |
| NKTR-102 Receives Positive Opinion From EMA COMP for Orphan Medicinal Product Designation in Ovarian Cancer | July 18, 2011 | Pharma News - PR Newswire |
| FDA Grants Orphan Drug Designation to 4SC AG's Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma | July 12, 2011 | BioSpace - Breaking News |
| FDA Grants Orphan Drug Designation to 4SC's Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma | July 12, 2011 | FDA News - Business Wire |
| FDA erteilt 'Orphan Drug'-Status für den oralen Pan-HDAC-Inhibitor Resminostat von 4SC zur Behandlung des hepatozellulären Karzinoms | July 12, 2011 | FDA News - Business Wire |
| Report: FDA Should Improve Approval Pathway for Orphan Drugs | July 07, 2011 | BioSpace |
| CytRx Corporation (CYTR) Receives FDA Orphan Drug Designation for INNO-206 for the Treatment of Soft Tissue Sarcomas | July 06, 2011 | Biotechnology - Moreover |
| Centric Health Resources Sponsors Fourth Annual Conference to Address Needs of Ultra Orphan Patients and Strategies for Delivering Value Outcomes | July 06, 2011 | Pharma News - Business Wire |
| CytRx Receives FDA Orphan Drug Designation for INNO-206 for the Treatment of Soft Tissue Sarcomas | July 05, 2011 | FDA News - Business Wire |
| Orphan drug status received in EU for PI-88: Progen | June 30, 2011 | Biotechnology - Moreover |
| Swedish Orphan Biovitrum AB (publ): Extraordinary General Meeting to decide on share program for new CEO | June 30, 2011 | Marketwire - Pharma and Biotech |
| Swedish Orphan Biovitrum: Change in agreement regarding additional purchase consideration for Multiferon(R) | June 30, 2011 | Marketwire - Pharma and Biotech |
| Geoffrey McDonough appointed President and CEO of Swedish Orphan Biovitrum | June 27, 2011 | Biotechnology - Moreover |
| ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells for Treatment of Stargardt's Disease | June 27, 2011 | Biotech News - PR Newswire |
| Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders | June 27, 2011 | Pharma News - PR Newswire |
| BioAlliance Pharma Submits Application for Orphan Medicinal Product Designation for Clonidine Lauriad™ in Europe and the United States | June 24, 2011 | Pharma News - Business Wire |
| Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Treatment of Two Autoimmune Diseases: Systemic Sclerosis & Hemolytic Anemia | June 23, 2011 | BioSpace - Breaking News |
| Repligen Corporation Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular Atrophy
| June 23, 2011 | BioSpace - Breaking News |
| Genetic Finding Offers Hope for Orphan Disease, Chuvash Polycythemia, Study | June 23, 2011 | BioSpace |
| Accentia Biopharmaceuticals Announces that FDA grants Orphan Drug Status for Revimmune™ Therapy for the Treatment of Two Autoimmune Diseases: Systemic Sclerosis & Hemolytic Anemia | June 23, 2011 | FDA News - Business Wire |
| Repligen Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular Atrophy | June 23, 2011 | FDA News - Business Wire |
| <b>Geoffrey McDonough</b> Appointed President and CEO of Swedish Orphan Biovitrum | June 22, 2011 | BioSpace - Breaking News |
| Ultragenyx Raises $45M in Series A to Progress Lead Orphan Disease Candidate into Clinic | June 20, 2011 | Inside Industry - Gen |
| German biotech calls for fair treatment of orphan drugs | June 17, 2011 | Biotechnology - Moreover |
| Lamellar happy to win orphan status | June 17, 2011 | Pharmaceutical - Moreover |
| Lamellar Biomedical Secures its First Orphan Drug Licence | June 16, 2011 | b3c newswire |
| Research and Markets: Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues - 2011 Edition | June 16, 2011 | Pharma News - Business Wire |
| CytRx Receives Orphan Drug Status For Pancreatic Cancer, Unigene Labs Enters Into Termination Agreement. | June 14, 2011 | Biotechnology - Moreover |
| US FDA grants orphan drug designation to Tengion's Neo-Urinary Conduit | June 13, 2011 | Biotechnology - Moreover |
| FDA gives orphan drug status to Tengion Neo-Urinary Conduit | June 10, 2011 | Biotechnology - Moreover |
| Morphotek Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations | June 08, 2011 | Pharmaceutical - Moreover |
| Edison Pharmaceuticals, Inc. Announces FDA Grants EPI-743 Orphan Drug Designation | June 08, 2011 | BioSpace - Breaking News |
| Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations | June 08, 2011 | Pharma News - PR Newswire |
| Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation | June 08, 2011 | Pharma News - PR Newswire |
| Mobius Therapeutics(TM) Granted Orphan Drug Designation for Refractive Indications | June 06, 2011 | Marketwire - Pharma and Biotech |
| Aradigm Receives FDA Orphan Drug Designation for Ciprofloxacin for Inhalation in Bronchiectasis | June 06, 2011 | FDA News - Business Wire |
| FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma | June 01, 2011 | Biotech News - PR Newswire |
| Omeros Corporation Unlocks Orphan GPCR Family Linked to Metabolic and Psychotic Disorders | May 31, 2011 | BioSpace - Breaking News |
| CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment | May 31, 2011 | Pharma News - PharmiWeb |
| YM BioSciences Announces Orphan Drug Designation for JAK1/JAK2 Inhibitor CYT387 in Europe | May 31, 2011 | Clinical Trials - PR Newswire |
| Omeros Unlocks Orphan GPCR Family Linked to Metabolic and Psychotic Disorders | May 31, 2011 | Pharma News - PR Newswire |
| DIA/ FDA Orphan Drug Designation Workshop | May 23, 2011 | Biotechnology - Moreover |
| Reportlinker Adds Orphan Drugs in Asia 2011 | May 23, 2011 | Medical Pharma - PR Newswire |
| Research and Markets: Amyotrophic Lateral Sclerosis - Orphan Status, Unmet Need, and Diverse Drug Targets Offer Opportunities for Drug Developers in United States | May 19, 2011 | Pharma News - Business Wire |
| Cytonet’s liver cell therapy granted orphan drug designation | May 18, 2011 | Biotechnology - Moreover |
| Orphan Europe Recordati S.p.A Receives 2011 Corporate Award From the
| May 18, 2011 | BioSpace - Breaking News |
| Orphan Europe (Recordati Group) Receives 2011 Corporate Award From the National Organization for Rare Disorders (NORD) | May 18, 2011 | Marketwire - Pharma and Biotech |
| Swiss Mondobiotech's drug candidate gets orphan designation in USA | May 18, 2011 | Biotechnology - Moreover |
| Cytonet's Liver Cell Therapy Awarded Orphan Drug Designation for the Treatment of Urea Cycle Disorders | May 17, 2011 | Biotech News - PR Newswire |
| FDA Grants Orphan Drug Designation for Mithridion, Inc.'s MCD-386CR to Treat Progressive Supranuclear Palsy | May 09, 2011 | BioSpace - Breaking News |
| Biogen Idec et Swedish Orphan Biovitrum reçoivent un avis favorable de l'EMA pour leur programme pédiatrique destiné à la thérapie à action prolongée pour l'hémophilie B | May 09, 2011 | Pharma News - Business Wire |
| Resumen: Biogen Idec y Swedish Orphan Biovitrum reciben opinión positiva de la EMA sobre plan pediátrico para terapia para la hemofilia B de larga duración | May 09, 2011 | Pharma News - Business Wire |
| Biogen Idec und Swedish Orphan Biovitrum erhalten EMA-Stellungnahme zu pädiatrischem Untersuchungsplan für lang wirkende Hämophilie-B-Therapie | May 09, 2011 | Pharma News - Business Wire |
| Biogen Idec and Swedish Orphan Biovitrum Receive Opinion from EMA on Pediatric Plan for Long-Lasting Hemophilia B Therapy | May 09, 2011 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Swedish Orphan Biovitrum ricevono il parere dell'EMA sul progetto pediatrico di terapia a lungo termine per l'emofilia B | May 09, 2011 | Pharma News - Business Wire |
| FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear Palsy | May 09, 2011 | Pharma News - PR Newswire |
| CytRx Corporation???s INNO-206 Receives FDA Approval for Orphan Drug Designation for Pancreatic Cancer | April 28, 2011 | BioSpace - Breaking News |
| CytRx’s INNO-206 Receives FDA Approval for Orphan Drug Designation for Pancreatic Cancer | April 28, 2011 | FDA News - Business Wire |
| Provectus Pharmaceuticals Inc. Receives Orphan Drug Designation from FDA for the Treatment of Liver Cancer | April 27, 2011 | BioSpace |
| Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011 | April 27, 2011 | Pharma News - PR Newswire |
| Provectus Receives Orphan Drug Designation from FDA for the Treatment of Liver Cancer | April 26, 2011 | FDA News - Business Wire |
| Nektar ovarian cancer drug gets FDA orphan status | April 21, 2011 | Health News - BizJournals.com |
| AiCuris Receives Orphan Drug Designation for its Innovative Phase II Drug AIC246 for the Prevention of HCMV Disease | April 21, 2011 | BioSpace - Breaking News |
| FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer | April 21, 2011 | Pharma News - PR Newswire |
| Research and Markets: Orphan Drugs: Strategic Approaches for the Industry 2011 | April 21, 2011 | Pharma News - Business Wire |
| FDA Grants Orphan Drug Designation For Nektar Therapeutics (AL)'s Investigational Drug (NKTR) | April 21, 2011 | BioSpace |
| AiCuris Receives Orphan Drug Designation for its Innovative Phase II Drug AIC246 for the ... | April 21, 2011 | b3c newswire |
| Amira Drug Gets Orphan Status | April 20, 2011 | Xconomy Life Sciences |
| Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis | April 19, 2011 | Pharma News - PR Newswire |
| Research and Markets: Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011 | April 08, 2011 | Pharma News - Business Wire |
| FDA approves orphan drug vandetanib | April 07, 2011 | Pharma News - PharmiWeb |
| Zacharon Nabs $210M Deal With Pfizer to Tackle Orphan Diseases | April 07, 2011 | Xconomy Life Sciences |
| Pfizer inks $210M orphan drug discovery pact with Zacharon | April 07, 2011 | FierceBiotech |
| FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid Cancer | April 06, 2011 | Pharma News - Business Wire |
| FDA Refuses to File Pfizer’s NDA for Orphan Drug Tafamidis | April 04, 2011 | Inside Industry - Gen |
| America Stem Cell, Inc. Receives Orphan Drug Designation for ASC-1 | March 30, 2011 | Biotechnology - Moreover |
| America Stem Cell, Inc. Receives Orphan Drug Designation for ASC-101 | March 30, 2011 | FDA News - Business Wire |
| Indian Companys Drug to Get Orphan Drug Status by US FDA | March 29, 2011 | Pharmaceutical - Moreover |
| Skinvisible, Inc. Submits Invisicare Formulation for FDA Orphan Drug Designation | March 23, 2011 | BioSpace - Breaking News |
| Orphan Drugs Warrant Flexibility On Clinical Pharmacology Data, FDA Panel Says | March 21, 2011 | Pharmaceutical - Moreover |
| FDA Grants 'Orphan Drug' Status to Aegerion Pharmaceuticals, Inc. Drug | March 16, 2011 | BioSpace |
| FDA Grants Orphan Drug Designation to Aegerion Pharmaceuticals, Inc.' Drug Candidate, Lomitapide, for Treatment of Familial Chylomicronemia | March 15, 2011 | BioSpace - Breaking News |
| FDA grants 'orphan drug' status to Aegerion drug | March 15, 2011 | Health News - CNBC |
| Cytonet: Leberzelltherapie erhält orphan drug-Status in USA | March 15, 2011 | Pharma News - Business Wire |
| Advanced Cell Technology Receives Positive Opinion for Orphan Drug Designation from European Medicines Evaluation Agency for hESC-Derived RPE Cells for Treatment of Stargardt's Disease | March 10, 2011 | BioSpace - Breaking News |
| ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt's Disease | March 10, 2011 | Biotech News - PR Newswire |
| Research and Markets: The Orphan Drug Report 2011 is Essential Reading for those Operating inside the Pharma Industry | March 10, 2011 | Pharma News - PharmiWeb |
| BiovaxID gets EMA orphan status | March 09, 2011 | FierceVaccines |
| Stemline Therapeutics, Inc. Receives Orphan Drug Designation for SL-401 for the Treatment of Acute Myeloid Leukemia | March 09, 2011 | BioSpace - Breaking News |
| Stemline AML Drug Gains Orphan Status | March 09, 2011 | Contract Pharma |
| Stemline Therapeutics Receives Orphan Drug Designation for SL-401 for the Treatment of Acute Myeloid Leukemia | March 09, 2011 | Clinical Trials - PR Newswire |
| Vanda Pharmaceuticals, Inc. Receives Orphan Drug Designation in Europe for tasimelteon | March 08, 2011 | BioSpace - Breaking News |
| Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer | March 08, 2011 | Pharma News - PR Newswire |
| Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon | March 08, 2011 | Biotech News - PR Newswire |
| Biovest is Awarded Orphan Drug Status for its Personalized Cancer Vaccine for the Treatment of Mantle Cell Lymphoma in European Union | March 07, 2011 | Pharma News - Business Wire |
| Talecris Biotherapeutics Receives EU Orphan Drug Designation for Plasmin (Human) as a Treatment for Acute Peripheral Arterial Occlusion | March 03, 2011 | Clinical Trials - PR Newswire |
| Celsion Corporation Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer | March 02, 2011 | BioSpace - Featured Stories |
| Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer | March 02, 2011 | Marketwire - Pharma and Biotech |
| Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive Disorders | March 02, 2011 | Pharma News - PR Newswire |
| Pervasis Therapeutics Receives Orphan Drug Designation in Europe for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis | March 01, 2011 | BioSpace - Breaking News |
| FDAAdvisoryCommittee.com to Webcast Discussions on Drug Development for Orphan and Rare Diseases | March 01, 2011 | Marketwire - Pharma and Biotech |
| Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis | March 01, 2011 | Pharma News - PR Newswire |
| Russian anticancer medicine granted orphan drug status in US | February 28, 2011 | Pharmaceutical - Moreover |
| Orphan Europe Selects Accredo Health Group to Distribute Carbaglu(R) | February 28, 2011 | Marketwire - Pharma and Biotech |
| MEDUNIK CANADA: A TEAM STRONGLY COMMITTED TO BRINGING NOVEL ORPHAN DRUGS TO CANADIANS WITH RARE DISEASES | February 28, 2011 | Biotech News - PR Newswire |
| Ohman axes rating on Swedish Orphan Biovitrum to "neutral" | February 25, 2011 | Pharmaceutical - Moreover |
| Ohman cuts Swedish Orphan Biovitrum to "neutral" | February 25, 2011 | Pharmaceutical - Moreover |
| PHARMSYNTHEZ GRANTED ORPHAN DRUG DESIGNATION FOR VIREXXA IN THE US | February 25, 2011 | Pharma News - PharmiWeb |
| iBio Announces Acquisition of Fabry Disease Orphan Drug Designation and Development Program | February 23, 2011 | Biotech News - Business Wire |
| Swedish Orphan Biovitrum Full Year Report 2010 | February 23, 2011 | Marketwire - Pharma and Biotech |
| Fate Therapeutics Announces Emerging Data From Proof-of-Concept FT1050 Clinical Trial and Receives Orphan Drug Designation | February 21, 2011 | Clinical Trials - PR Newswire |
| miRagen Therapeutics Receives Orphan Drug Designation for MGN-4893 for the Treatment of Polycythemia Vera | February 17, 2011 | FDA News - Business Wire |
| Cerus Corporation's INTERCEPT Plasma Granted Orphan Drug Designation for Treatment of Thrombotic Thrombocytopenic Purpura (TTP) | February 16, 2011 | BioSpace - Breaking News |
| Cerus' INTERCEPT Plasma Granted Orphan Drug Designation for Treatment of Thrombotic Thrombocytopenic Purpura (TTP) | February 16, 2011 | FDA News - Business Wire |
| BrainStorm Cell Therapeutics Inc. Receives FDA Orphan Drug Designation for NurOwn(TM) in the Treatment of Amyotrophic Lateral Sclerosis | February 14, 2011 | BioSpace - Breaking News |
| BrainStorm’s NurOwn Gets Orphan Status | February 14, 2011 | Contract Pharma |
| BrainStorm Receives FDA Orphan Drug Designation for NurOwn™ in the Treatment of Amyotrophic Lateral Sclerosis | February 14, 2011 | FDA News - Business Wire |
| FDA Gives NeuralStem Inc.'s Experimental ALS Treatment Orphan Status | February 10, 2011 | BioSpace - Breaking News |
| FDA Gives Neuralstem's Experimental ALS Treatment Orphan Status | February 09, 2011 | Health News - Fox Business |
| Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS | February 09, 2011 | Pharma News - PR Newswire |
| FDA Grants Orphan Drug Designation to Bayer HealthCare AG's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors | February 04, 2011 | BioSpace - Breaking News |
| Bayer's regorafenib gets orphan drug designation | February 04, 2011 | FierceBiotech |
| FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors | February 04, 2011 | Pharma News - PR Newswire |
| Orphan Drug Designation Workshop | February 03, 2011 | Biotechnology - Moreover |
| Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs | February 03, 2011 | Pharma News - PR Newswire |
| FDA Awards EGEN, Inc. Orphan - Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer | February 02, 2011 | BioSpace - Breaking News |
| FDA Awards EGEN, Inc. Orphan -Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer | February 02, 2011 | Clinical Trials - PR Newswire |
| Regulatory Roundup: FDA Holds Workshop on Orphan Drugs | February 02, 2011 | Biotechnology - Moreover |
| NPS soars on positive Ph3 data for orphan SBS drug | January 31, 2011 | FierceBiotech |
| KGI to Celebrate Rare Disease Day With Orphan Drug Workshop | January 31, 2011 | Medical Pharma - PR Newswire |
| RRD partners with NIH for orphan drug development | January 28, 2011 | Pharmaceutical - Moreover |
| Fourth FDA Orphan Drug Designation Workshop Scheduled for Feb. 28 - March 1, 2011 | January 27, 2011 | Pharma News - PR Newswire |
| Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab(R) | January 27, 2011 | Marketwire - Pharma and Biotech |
| Alnylam Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation from European Medicines Evaluation Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis | January 25, 2011 | BioSpace - Breaking News |
| BioSante Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine | January 25, 2011 | BioSpace - Breaking News |
| BioSante Pharma receives orphan drug status | January 25, 2011 | Health News - CNBC |
| Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis | January 25, 2011 | Pharma News - Business Wire |
| BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine | January 25, 2011 | FDA News - Business Wire |
| Mobius Theraputics??? Granted Orphan Drug Designation for Cornea Indication | January 21, 2011 | BioSpace - Breaking News |
| Mobius Therapeutics(TM) Granted Orphan Drug Designation for Cornea Indication | January 21, 2011 | Marketwire - Pharma and Biotech |
| ZIOPHARM, Inc. Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines Agency | January 20, 2011 | BioSpace - Breaking News |
| Soligenix Receives FDA Orphan Drug Designation for RiVax(TM) for the Prevention of Ricin Intoxication | January 20, 2011 | BioSpace - Breaking News |
| Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication | January 20, 2011 | Biotech News - PR Newswire |
| ZIOPHARM Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines Agency | January 20, 2011 | FDA News - Business Wire |
| <b>CureFAKtor Pharmaceuticals</b> Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer | January 18, 2011 | BioSpace - Breaking News |
| CureFAKtor Pharmaceuticals Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer | January 18, 2011 | Biotech News - PR Newswire |
| Swedish Orphan Biovitrum and BL&H Co., Ltd sign distribution agreement for South Korea | January 11, 2011 | Marketwire - Pharma and Biotech |
| Exelixis, Inc.'s XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib | January 10, 2011 | BioSpace - Breaking News |
| Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib | January 10, 2011 | FDA News - Business Wire |
| Optimer Pharmaceuticals, Inc. Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection | January 04, 2011 | BioSpace - Breaking News |
| Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection | January 04, 2011 | Biotech News - PR Newswire |
| Senesco Technologies, Inc. Lead Therapeutic Candidate SNS01-T Granted Orphan Drug Status from FDA for Treatment of Multiple Myeloma | January 03, 2011 | BioSpace - Breaking News |
| Senesco Technologies’ Lead Therapeutic Candidate SNS01-T Granted Orphan Drug Status from FDA for Treatment of Multiple Myeloma | January 03, 2011 | Pharma News - Business Wire |
| Swedish Orphan Biovitrum Drops Joint Project with Symphogen A/S | December 30, 2010 | BioSpace |
| Swedish Orphan Biovitrum Returns Development Rights to Sym001 to Symphogen | December 30, 2010 | Marketwire - Pharma and Biotech |
| Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Receives Orphan Drug Status Designation for CEQ508 for the Treatment of Familial Adenomatous Polyposis | December 29, 2010 | BioSpace - Breaking News |
| Marina Biotech Receives Orphan Drug Status Designation for CEQ508 for the Treatment of Familial Adenomatous Polyposis | December 29, 2010 | Marketwire - Pharma and Biotech |
| Pharming and Swedish Orphan Biovitrum announce first sales of Ruconest in Europe | December 28, 2010 | Marketwire - Pharma and Biotech |
| FORMER HIV drug developer Avexa is keeping mum about whether it has applied for orphan drug designation for apricitabine (ATC) in the US, but has revealed it has spoken to a handful of large pharmaceutical companies about the asset since July. | December 24, 2010 | Pharmaceutical - Moreover |
| Advanced Cell Technology Files in Europe for Orphan Drug Designation For Its RPE Cells for Treatment of Stargardt’s Disease | December 23, 2010 | Pharma News - Business Wire |
| Swedish Orphan Biovitrum's Long-Lasting Hemophilia A Therapy Receives Orphan Drug Designation in the US | December 23, 2010 | Marketwire - Pharma and Biotech |
| Iran Produces Nanosensor for Measuring Dextromethorphan in Cough Drugs | December 21, 2010 | Pharmaceutical - Moreover |
| Swedish Orphan Biovitrum to increase the availability of Willfact(R) to von Willebrand patients as LFB BIOMEDICAMENTS has received additional European regulatory approvals | December 20, 2010 | Marketwire - Pharma and Biotech |
| Children's Hospitals and Clinics of Minnesota Applauds Fix on 'Orphan Drug' Coverage | December 16, 2010 | Medical Pharma - PR Newswire |
| Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia | December 14, 2010 | Pharmaceutical - Moreover |
| Resumen: Biogen Idec y Swedish Orphan Biovitrum anuncian primera administración a paciente de su proteína de fusión Factor VIII Fc recombinante de acción duradera en ensayo de homologación mundial | December 13, 2010 | Pharma News - Business Wire |
| QLT Ophthalmics, Inc. (QOI) Receives Orphan Drug Designation for QLT091001 to Treat Retinitis Pigmentosa | December 08, 2010 | BioSpace - Breaking News |
| Orphan Drug Discounts Ended for Children’s Hospitals | December 07, 2010 | New York Times- Pharmaceuticals |
| NeuroVive Obtains U.S. Orphan Drug Designation for Traumatic Brain Injury (MRW) | December 06, 2010 | Pharmaceutical - Moreover |
| Samenvatting: Biogen Idec en Swedish Orphan Biovitrum maken behandeling van eerste patiënt bekend in mondiaal registratief onderzoek naar langdurig recombinant factor VIII Fc fusie-eiwit | December 06, 2010 | Pharma News - Business Wire |
| FDA grants orphan drug status to NeuroVive Pharma NeuroSTAT | December 06, 2010 | Pharmaceutical - Moreover |
| Biogen Idec et Swedish Orphan Biovitrum annoncent le dosage réussi du premier patient dans le cadre d’un essai mondial d’homologation de la protéine de fusion Fc-facteur VIII recombinante à action prolongée | December 06, 2010 | Pharma News - Business Wire |
| Biogen Idec und Swedish Orphan Biovitrum melden erstmalige Gabe ihres langwirkenden rekombinanten Faktor-VIII-Fc-Fusionsproteins an Patienten in globaler Zulassungsstudie | December 06, 2010 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Swedish Orphan Biovitrum annunciano la prima somministrazione della proteina di fusione ricombinante a lungo termine costituita dal fattore VIII... | December 06, 2010 | Pharma News - Business Wire |
| NeuroVive Obtains U.S. Orphan Drug Designation for Traumatic Brain Injury | December 06, 2010 | Marketwire - Pharma and Biotech |
| Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Lasting Recombinant Factor VIII Fc Fusion Protein | December 06, 2010 | Pharma News - Business Wire |
| Cleveland BioLabs' CBLB502 Granted Orphan Drug Status From FDA for Prevention of Death Following a Potentially Lethal Dose of Total Body Irradiation During or After a Radiation Disaster | November 30, 2010 | Marketwire - Pharma and Biotech |
| Elorac, Inc. Announces Orphan Drug Designation for Novel Topical Treatment for Pruritus in Cutaneous T-cell Lymphoma (CTCL) | November 30, 2010 | Pharma News - Business Wire |
| EBE and EuropaBio hail EU Orphan Medicinal Products Regulation a success | November 29, 2010 | Biotechnology - Moreover |
| CEO Leaves Swedish Orphan Biovitrum | November 29, 2010 | BioSpace - Breaking News |
| CEO Martin Nicklasson Leaves Swedish Orphan Biovitrum | November 25, 2010 | Marketwire - Pharma and Biotech |
| Almac Adds Late Stage Customisation Suite to Assist Orphan Drug / Niche Product Launches Into Europe | November 25, 2010 | Biotech News - PR Newswire |
| INTERVIEW: Shire CEO Says Orphan Drugs Focus Good Pharma Model | November 22, 2010 | Health News - Fox Business |
| Close legal loophole allowing highcost orphan drugs doctors say | November 19, 2010 | Pharmaceutical - Moreover |
| Advanced Life Sciences Holdings, Inc. Applies for FDA Orphan Drug Designation for ALS-886 to Treat Acute Lung Injury | November 18, 2010 | BioSpace - Breaking News |
| Advanced Life Sciences Applies for FDA Orphan Drug Designation for ALS-886 to Treat Acute Lung Injury | November 18, 2010 | Biotech News - PR Newswire |
| Orphan Medicinal Product Status to Active Biotech's 57-57 project recommended | November 18, 2010 | Marketwire - Pharma and Biotech |
| Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease | November 15, 2010 | Biotech News - PR Newswire |
| Celsion Corporation Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox(R) to Treat Primary Liver Cancer | November 11, 2010 | BioSpace - Breaking News |
| Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer | November 11, 2010 | Clinical Trials - PR Newswire |
| German Pharmaceutical Law Removes Incentives For Orphan Drug R | November 11, 2010 | Biotechnology - Moreover |
| German Pharmaceutical Law Removes Incentives For Orphan Drug R&D | November 11, 2010 | Pharmaceutical - Moreover |
| Semafore Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation for SF1126 in the Treatment of Chronic Lymphocytic Leukemia | November 09, 2010 | BioSpace - Breaking News |
| Synageva BioPharma Receives European Orphan Medicinal Product Designation for SBC-102 for Lysosomal Acid Lipase Deficiency | November 09, 2010 | Pharma News - Business Wire |
| Semafore Pharmaceuticals Receives FDA Orphan Drug Designation for SF1126 in the Treatment of Chronic Lymphocytic Leukemia | November 09, 2010 | FDA News - Business Wire |
| Omeros Identifies Orphan GPCR-Targeting Compound Potentiating Chemotherapeutic Activity | November 09, 2010 | Biotech News - PR Newswire |
| Swedish Orphan Biovitrum's co-promotion rights for Mimpara® sold back to Amgen | November 05, 2010 | Pharma News - PharmiWeb |
| Swedish Orphan Biovitrum's Co-Promotion Rights for Mimpara(R) Sold Back to Amgen | November 05, 2010 | Marketwire - Pharma and Biotech |
| Emergent BioSolutions Receives Orphan Drug Designation for Its Investigational Monoclonal Antibody for the Treatment of Inhalation Anthrax | November 04, 2010 | FDA News - Business Wire |
| Swedish Orphan Biovitrum And Announce A Distribution Agreement For Iron Sucrose Rechon In Europe | November 03, 2010 | BioSpace - Breaking News |
| Swedish Orphan Biovitrum AB (publ): Swedish Orphan Biovitrum and Dongbao Group announce a distribution agreement for Iron Sucrose Rechon in Europe | November 03, 2010 | Pharmaceutical - Moreover |
| Swedish Orphan Biovitrum and Dongbao Group announce a distribution agreement for Iron Sucrose Rechon in Europe | November 03, 2010 | Marketwire - Pharma and Biotech |
| Neogenix Oncology® Receives FDA Orphan Drug Status for Ensituximab (NPC-1C) for Treatment of Pancreatic Cancer | November 01, 2010 | FDA News - Business Wire |
| AOP Orphan Gives €1.25M Up Front in Deal for Shield’s Phase III-Stage Iron Therapy Product | November 01, 2010 | Inside Industry - Gen |
| Clinical Data, Inc. Granted Orphan Drug Designation for PRX-8066 for Pulmonary Arterial Hypertension | November 01, 2010 | Pharma News - Business Wire |
| Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021 | November 01, 2010 | Pharma News - PR Newswire |
| Strativa Pharma enters amended agreement with Swedish Orphan Biovitrum for Nascobal | October 29, 2010 | Pharmaceutical - Moreover |
| Strativa Pharmaceuticals signs agreement with Swedish Orphan Biovitrum for Nascobal | October 27, 2010 | Pharmaceutical - Moreover |
| Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum ... | October 26, 2010 | Pharmaceutical - Moreover |
| Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum Regarding Nascobal® | October 26, 2010 | Pharma News - PR Newswire |
| Europäische Arzneimittelbehörde beurteilt Antrag der Cytonet GmbH & Co. KG auf Orphan Drug-Status für Leberzelltherapie positiv | October 26, 2010 | Pharma News - Business Wire |
| Inspiration Biopharmaceuticals' OBI-1 Receives Orphan Drug Designation in Europe | October 19, 2010 | Medical Pharma - PR Newswire |
| Ipsen: OBI-1 Receives Orphan Drug Designation in Europe | October 19, 2010 | FDA News - Business Wire |
| S*BIO's JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission (EC) for the Treatment of Myelofibrosis (MF) | October 18, 2010 | Biotech News - PR Newswire |
| Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Hodgkin Lymphoma by the European Commission | October 15, 2010 | Pharma News - Business Wire |
| FDA Schedules Third Orphan Drug Workshop for Nov. 4-5, 2010 | October 13, 2010 | Pharma News - PR Newswire |
| Pharmalink AB Receives US Orphan Drug Designation for Nefecon(R) (PL-56) | October 13, 2010 | Pharma News - PR Newswire |
| NeuroVive Pharma NeuroSTAT gets orphan drug status | October 12, 2010 | Pharmaceutical - Moreover |
| Genta Incorporated Tesetaxel Granted Orphan Drug Designation for Gastric Cancer by European Medicines Evaluation Agency | October 11, 2010 | BioSpace - Featured Stories |
| Tesetaxel Granted Orphan Drug Designation for Gastric Cancer by European Medicines Agency | October 11, 2010 | Pharma News - Business Wire |
| NeuroVive receives Orphan Drug Designation in Europe for moderate and severe traumatic brain injury | October 11, 2010 | Marketwire - Pharma and Biotech |
| Symphogen and Swedish Orphan Biovitrum receive U.S. orphan drug designation for Rozrolimupab in ITP | October 06, 2010 | Marketwire - Pharma and Biotech |
| AEterna Zentaris Announces Orphan Drug AEZS-130 (Macimorelin, SolorelTM) Interim Phase 3 Data Analysis Shows Potential for 2011 Filing as Oral Diagnostic Test for Adult Growth Hormone Deficiency (AGHD) | October 05, 2010 | BioSpace - Breaking News |
| Prolor Biotech Gets Orphan Drug Designation for Growth Hormone Deficiency Treatment | October 05, 2010 | Health News - Fox Business |
| Aeterna Zentaris Announces Orphan Drug AEZS-130 (Macimorelin, Solorel(TM)) Interim Phase 3 Data Analysis Shows Potential for 2011 Filing as Oral Diagnostic Test for Adult Growth Hormone Deficiency (AGHD) | October 05, 2010 | Biotech News - PR Newswire |
| PROLOR Biotech Rallies on Orphan Status for Growth Therapy | October 05, 2010 | BioSpace - Breaking News |
| Prolor growth hormone gets 'orphan drug' status | October 05, 2010 | Health News - CNBC |
| Orphan Drug Report 2010 | October 05, 2010 | Pharmaceutical - Moreover |
| PROLOR Biotech's Longer-Acting Human Growth Hormone Receives Orphan Drug Designation in the U.S. | October 05, 2010 | Biotech News - PR Newswire |
| iCo Therapeutics Inc. Oral Amphotericin Program Receives FDA Orphan Drug Status | September 29, 2010 | BioSpace - Breaking News |
| iCo Therapeutics Oral Amphotericin Program Receives FDA Orphan Drug Status | September 29, 2010 | Marketwire - Pharma and Biotech |
| AMT gene therapy receives orphan drug status in USA | September 24, 2010 | Biotechnology - Moreover |
| AMT Receives Orphan Drug Designation From the U.S. Food and Drug Administration Duchenne Muscular Dystrophy Gene Therapy | September 24, 2010 | Biotech News - PR Newswire |
| Ziopharm Oncology Treatment for T-cell Lymphoma Receives Orphan Drug Designation | September 23, 2010 | Health News - Fox Business |
| ZIOPHARM Oncology, Inc.'s Lymphoma Drug Darinaparsin Gets FDA Orphan Status | September 23, 2010 | BioSpace - Breaking News |
| Ziopharm drug candidate awarded orphan drug status | September 23, 2010 | Health News - CNBC |
| ZIOPHARM Receives FDA Orphan Drug Designation for Darinaparsin in the Treatment of Peripheral T-cell Lymphoma | September 23, 2010 | FDA News - Business Wire |
| Swedish Orphan Biovitrum's Hemophilia A Therapy Receives European Commission Orphan Drug Designation | September 23, 2010 | Marketwire - Pharma and Biotech |
| UPDATE 1-Catalyst's infantile spasm drug gets FDA orphan status | September 21, 2010 | Pharmaceutical - Moreover |
| PTC Therapeutics Receives $1.6M from FDA Orphan Drug Grant | September 21, 2010 | Inside Industry - Gen |
| PTC Therapeutics Awarded $1.6 Million FDA Orphan Drug Grant to Support an Ongoing Phase 3 Study in Cystic Fibrosis | September 21, 2010 | Biotech News - PR Newswire |
| Shire joins orphan disease rush with $500 million Acceleron deal | September 09, 2010 | Pharmaceutical - Moreover |
| Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire plc on Novel Muscle Therapeutics for Orphan Diseases in Deal Worth up to $498 Million | September 09, 2010 | BioSpace |
| Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire plc on Novel Muscle Therapeutics for Orphan Diseases; to Make Upfront Payment of $45 Million with Potential for Additional $288 Million | September 09, 2010 | BioSpace |
| Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma | September 09, 2010 | Biotech News - PR Newswire |
| Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire on Novel Muscle Therapeutics for Orphan Diseases | September 09, 2010 | Pharma News - Business Wire |
| Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe | September 08, 2010 | Pharmaceutical - Moreover |
| Research and Markets: Orphan Drug Report 2010 Profiles More than 80 Drugs Out Today | September 06, 2010 | Pharma News - Business Wire |
| Pompe drug wins orphan status | September 01, 2010 | Pharmaceutical - Moreover |
| Pfizer Makes Another Move into Orphan Drug Development with Purchase of FoldRx | September 01, 2010 | Inside Industry - Gen |
| Stromedix drug candidate gets orphan designation | August 31, 2010 | Biotechnology - Moreover |
| Stromedix, Inc. Receives FDA Orphan Drug Designation for STX-100 for the Treatment of Idiopathic Pulmonary Fibrosis | August 31, 2010 | BioSpace - Breaking News |
| New number of shares and votes in Swedish Orphan Biovitrum AB (publ) | August 31, 2010 | Marketwire - Pharma and Biotech |
| Stromedix Receives FDA Orphan Drug Designation for STX-100 for the Treatment of Idiopathic Pulmonary Fibrosis | August 31, 2010 | FDA News - Business Wire |
| BioMarin Pharmaceutical Inc. (BMRN) Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease | August 30, 2010 | Pharmaceutical - Moreover |
| BioMarin's Pompe disease drug gets orphan status | August 30, 2010 | Health News - CNBC |
| BioMarin Pharmaceutical Inc. Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease | August 30, 2010 | BioSpace - Breaking News |
| BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease | August 30, 2010 | Biotech News - PR Newswire |
| Swedish Orphan Biovitrum AB's Kineret(R) has Received Orphan Drug Designation in the USA | August 26, 2010 | BioSpace - Breaking News |
| LFB S.A.'s Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in the USA for Chronic Lymphocytic Leukemia | August 26, 2010 | BioSpace - Breaking News |
| LFB's Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in the USA for Chronic Lymphocytic Leukemia | August 26, 2010 | FDA News - Business Wire |
| Swedish Orphan Biovitrum's Kineret(R) has Received Orphan Drug Designation in the USA | August 26, 2010 | Marketwire - Pharma and Biotech |
| FDA Grants Orphan Drug Status for to-BBB's Lead Product | August 23, 2010 | BioSpace - Breaking News |
| Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant | August 23, 2010 | Biotech News - PR Newswire |
| Acceleron Pharma Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy | August 19, 2010 | BioSpace - Breaking News |
| Acceleron Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy | August 19, 2010 | FDA News - Business Wire |
| BioMarin snares orphan disease upstart in $115M buyout | August 19, 2010 | Pharmaceutical - Moreover |
| ImmunoGen's Small-Cell Lung Cancer Treatment Receives Orphan Drug Designation | August 18, 2010 | Health News - Fox Business |
| UPDATE 1-ImmunoGen lung cancer drug gets FDA orphan status | August 18, 2010 | Biotechnology - Moreover |
| ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer | August 18, 2010 | Pharma News - Business Wire |
| NephRx Corporation Receives Orphan Drug Designation for NX001 for Prevention of Delayed Kidney Graft Function | August 18, 2010 | BioSpace - Breaking News |
| BioMarin snares orphan drug upstart in $115M buyout | August 18, 2010 | FierceBiotech |
| NephRx Corp. Receives Orphan Drug Designation for NX001 for Prevention of Delayed Kidney Graft Function | August 18, 2010 | Biotech News - PR Newswire |
| BioMimetic Therapeutics drug gets orphan status | August 12, 2010 | Health News - CNBC |
| BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteochondritis Dissecans | August 12, 2010 | FDA News - Business Wire |
| Centric Health Resources Presents Third Annual Ultra Orphan Conference 2010, Emerging Commercialization Strategies for Addressing the Needs of Ultra- | August 11, 2010 | Pharmaceutical - Moreover |
| Centric Health Resources Presents Third Annual Ultra Orphan Conference 2010, “Emerging Commercialization Strategies for Addressing the Needs of Ultra- Orphan Patients” | August 11, 2010 | Pharma News - Business Wire |
| Reportlinker Adds Global Markets for Orphan Drugs | August 10, 2010 | Pharma News - PR Newswire |
| YM BioSciences JAK1/2 Inhibitor Gets Orphan Designation | August 10, 2010 | Contract Pharma |
| YM BioSciences granted Orphan Drug Designation for CYT387 | August 10, 2010 | Biotech News - PR Newswire |
| DUSA Pharmaceuticals to Stop Levulan Photodynamic Cancer Trial as FDA Denies Orphan Status | August 09, 2010 | BioSpace - Breaking News |
| DUSA Pharmaceuticals Receives Response From FDA on Orphan Drug Designation Status | August 06, 2010 | Pharma News - PR Newswire |
| Orphan Drug Industry in the Development of the Biotechnology Industry | August 06, 2010 | Biotechnology - Moreover |
| XOMA (US) LLC Release: XOMA 052 Designated Orphan Drug by FDA for Treatment of Behcet's Disease | August 04, 2010 | BioSpace - Breaking News |
| FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder | August 02, 2010 | Pharma News - PR Newswire |
| Biovest wins orphan drug status for cancer vax | July 29, 2010 | FierceVaccines |
| Biovest International product gets orphan drug status from FDA | July 26, 2010 | Health News - BizJournals.com |
| FDA Grants Biovest International, Inc. Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID(R), Targeting Mantle Cell Lymphoma | July 26, 2010 | BioSpace |
| FDA Grants Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID®, Targeting Mantle Cell Lymphoma | July 26, 2010 | FDA News - Business Wire |
| Centric Health Resources Identifies Emerging Channels to Reach Patients in Specialty and Orphan Markets at Bio/Pharmaceutical and Medical Device Forum | July 26, 2010 | Pharmaceutical - Moreover |
| Global Markets for Orphan Drugs | July 19, 2010 | Biotechnology - Moreover |
| Keryx's shares rally on new orphan drug title for perifosine | July 15, 2010 | FierceBiotech |
| Keryx's perifosine gets second orphan drug status | July 15, 2010 | Health News - CNBC |
| Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX-0401 (Perifosine) for the Treatment of Neuroblastoma | July 14, 2010 | Pharma News - PR Newswire |
| Resumen: Biogen Idec y Swedish Orphan Biovitrum presentan datos sobre terapia de larga duración para la hemofilia B en el Congreso de la Federación Mundial de la Hemofilia | July 13, 2010 | Pharma News - Business Wire |
| Biogen Idec und Swedish Orphan Biovitrum präsentieren auf dem Kongress der World Federation of Hemophilia Daten zu lang wirkender Hämophilie-B-Therapie | July 12, 2010 | Pharma News - Business Wire |
| Biogen Idec et Swedish Orphan Biovitrum présentent les résultats du traitement de l'hémophilie B à action prolongée lors du congrès de la Fédération mondiale de l'hémophilie | July 12, 2010 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Swedish Orphan Biovitrum presentano i dati sulla terapia per l'emofilia B a lungo termine al congresso della Federazione mondiale per l'emofilia | July 12, 2010 | Pharma News - Business Wire |
| Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the Congress | July 12, 2010 | BioSpace - Breaking News |
| Samenvatting: Biogen Idec en Swedish Orphan Biovitrum presenteren gegevens over langdurige behandeling hemofilie B tijdens World Federation of Hemophilia Congress | July 12, 2010 | Biotech News - Business Wire |
| Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress | July 12, 2010 | Pharma News - Business Wire |
| Biogen Idec und Orphan Biovitrum aus Schweden beschließen Weiterentwicklung von langwirkendem Hämophilie-A-Medikament in einer Zulassungsstudie | July 12, 2010 | Pharma News - Business Wire |
| Biogen Idec et Swedish Orphan Biovitrum annoncent leur décision de soumettre leur traitement de l’hémophilie A à action prolongée à un essai d’homologation | July 09, 2010 | Pharma News - Business Wire |
| Biogen Idec, Inc. (North Carolina) and Swedish Orphan Biovitrum AB Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational Trial | July 09, 2010 | BioSpace - Breaking News |
| Biogen, Inc. and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial | July 09, 2010 | BioSpace - Breaking News |
| Samenvatting: Biogen Idec en Swedish Orphan Biovitrum melden promotie van langdurige hemofilie A-therapie tot een registrationeel onderzoek | July 09, 2010 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Swedish Orphan Biovitrum annunciano decisione di far avanzare terapia per emofilia A a lungo termine a sperimentazione registrativa | July 09, 2010 | Pharma News - Business Wire |
| Biogen Idec and Swedish Orphan Biovitrum Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational Trial | July 09, 2010 | Marketwire - Pharma and Biotech |
| Resumen: Biogen Idec y Swedish Orphan Biovitrum anuncian decisión de avanzar la terapia de larga duración para la hemofilia A en ensayo clínico de registro | July 09, 2010 | Biotech News - Business Wire |
| Biogen Idec and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial | July 09, 2010 | Pharma News - Business Wire |
| Synageva BioPharma Receives Orphan Drug Designation for SBC-102 for Lysosomal Acid Lipase Deficiency | July 07, 2010 | FDA News - Business Wire |
| Swedish Orphan Biovitrum AB (publ) (SE) - Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European markets | July 06, 2010 | Pharmaceutical - Moreover |
| Angeion Corporation Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3 | July 06, 2010 | BioSpace - Breaking News |
| Angion Biomedica Corp. Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3 | July 06, 2010 | BioSpace |
| Angion Biomedica Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3 | July 06, 2010 | FDA News - Business Wire |
| Swedish Orphan Biovitrum AB (publ): Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European markets | July 06, 2010 | Pharmaceutical - Moreover |
| Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European markets | July 06, 2010 | Marketwire - Pharma and Biotech |
| NORD Calls for Statement of Policy on Orphan Drug Development | June 29, 2010 | Pharma News - PR Newswire |
| Omeros Successfully Unlocks Orphan GPCRs | June 29, 2010 | Biotech News - PR Newswire |
| Tarix Pharmaceuticals' TXA127 Receives FDA Orphan Drug Designation for Stem Cell Engraftment | June 28, 2010 | Pharma News - PR Newswire |
| Chiasma Receives Orphan Drug Designation From the FDA for Octreolin™ for the Oral Treatment of Acromegaly | June 28, 2010 | Biotech News - PR Newswire |
| AVEO Gets Orphan Designation From EU Regulators | June 24, 2010 | Biotechnology - Moreover |
| Avraham Pharmaceuticals Ltd. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency | June 24, 2010 | BioSpace - Breaking News |
| t2cure GmbH???s Cellular Therapeutic Receives Orphan Drug Designation from FDA, European Medicines Evaluation Agency Recommendation for Buerger???s Disease | June 24, 2010 | BioSpace |
| Aveo cancer drug gets orphan status in Europe | June 24, 2010 | Health News - CNBC |
| AVEO Pharmaceuticals, Inc. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency | June 24, 2010 | BioSpace - Breaking News |
| t2cure's Cellular Therapeutic Receives Orphan Drug Designation from FDA, EMA Recommendation for Buerger's Disease | June 24, 2010 | Biotech News - PR Newswire |
| AVEO Pharmaceuticals, Inc. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Agency | June 24, 2010 | Pharma News - Business Wire |
| Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitus | June 22, 2010 | Biotech News - PR Newswire |
| Allos Therapeutics, Inc.' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Cutaneous T-Cell Lymphoma by the European Commission | June 17, 2010 | BioSpace - Breaking News |
| OBI-1 Developed by Ipsen and Inspiration Biopharmaceuticals Has Obtained a Positive Opinion for the Orphan Drug Status in Europe | June 17, 2010 | BioSpace - Breaking News |
| Raptor Wins EU Orphan Status for Kidney Disease Drug | June 17, 2010 | Pharmaceutical - Moreover |
| Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Cutaneous T-Cell Lymphoma by the European Commission | June 17, 2010 | Pharma News - Business Wire |
| OBI-1 Developed by Ipsen and Inspiration Has Obtained a Positive Opinion for the Orphan Drug Status in Europe | June 17, 2010 | Pharma News - Business Wire |
| Raptor’s DR Cysteamine Gets Orphan Designation From EMA | June 16, 2010 | Pharmaceutical - Moreover |
| Raptor Pharmaceutical Inc.'s DR Cysteamine Receives Orphan Medicinal Product Designation From the European Medicines Evaluation Agency | June 15, 2010 | BioSpace - Breaking News |
| UK grants Quark orphan drug status | June 15, 2010 | Health News - BizJournals.com |
| Quark Granted European Orphan Drug Status for QPI-1002 for the Prophylaxis of Delayed Graft Function in Kidney Transplant Patients | June 15, 2010 | Pharma News - PR Newswire |
| ImmunoCellular Therapeutics, Ltd Granted Orphan Drug Status for ICT-107 | June 11, 2010 | BioSpace - Breaking News |
| ImmunoCellular Therapeutics Granted Orphan Drug Status for ICT-107 | June 11, 2010 | FDA News - Business Wire |
| FDA gives orphan status to BioSante leukemia drug | June 07, 2010 | Health News - CNBC |
| BioSante Announces FDA Orphan Drug Designation for GVAX Chronic Myeloid Leukemia Cancer Vaccine | June 07, 2010 | FDA News - Business Wire |
| ACT Biotech Receives Orphan Drug Designation for Telatinib, an Orally Available and Highly Selective Kinase Inhibitor, in Gastric Cancer | June 02, 2010 | FDA News - Business Wire |
| Trappsol(R) Cyclo(TM) Awarded Orphan Drug Status | June 01, 2010 | Marketwire - Pharma and Biotech |
| Repligen drug gets FDA orphan drug status | May 24, 2010 | Health News - CNBC |
| Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia | May 24, 2010 | Biotech News - PR Newswire |
| Allos Therapeutics, Inc.'s Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder Cancer | May 18, 2010 | BioSpace |
| Allos Therapeutics’ Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder Cancer | May 18, 2010 | FDA News - Business Wire |
| AEterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the of the | May 17, 2010 | BioSpace |
| NeoPharm Drug Gets Orphan Designation | May 17, 2010 | Contract Pharma |
| Orphan drug status for Aeterna's cancer treatment | May 17, 2010 | Health News - CNBC |
| NeoPharm Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis | May 17, 2010 | FDA News - Business Wire |
| Aeterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the Committee for Orphan Medicinal Products of the European Medicines Agency | May 17, 2010 | Medical Pharma - PR Newswire |
| Swedish Orphan Biovitrum and Biomodels to develop assay for mucositis risk in cancer treatment | May 11, 2010 | Marketwire - Pharma and Biotech |
| Aeterna Zentaris Cancer Drug Gets Orphan Drug Designation | May 07, 2010 | Contract Pharma |
| US FDA seeks input on orphan product regulation | May 06, 2010 | Pharmaceutical - Moreover |
| Swedish Orphan Biovitrum presents first positive Kiobrina(R) clinical phase II data | May 06, 2010 | Marketwire - Pharma and Biotech |
| Osiris Therapeutics Receives FDA Orphan Drug Designation for Stem Cell Treatment for Type 1 Diabetes | May 04, 2010 | FDA News - Business Wire |
| Synageva BioPharma Files for Orphan Drug Designation for SBC-102, Being Developed to Be the First Enzyme Replacement Therapy to Treat Lysosomal Acid Lipase Deficiency – a Progressive, Often Fatal Disease | May 04, 2010 | FDA News - Business Wire |
| Valeant to buy orphan drug developer Aton for $318mn | May 04, 2010 | Pharmaceutical - Moreover |
| Valeant to buy orphan drug developer Aton for $318M | May 03, 2010 | FierceBiotech |
| ImmunoCellular Files Orphan Drug Application for ICT-107 | May 03, 2010 | Pharma News - Business Wire |
| Swedish Orphan Biovitrum AB Has Decided To Move Kiobrina(R) Into Phase III Development | April 21, 2010 | BioSpace - Breaking News |
| Swedish Orphan Biovitrum has decided to move Kiobrina(R) into phase III development | April 21, 2010 | Marketwire - Pharma and Biotech |
| CytRx’s Bafetinib Receives Positive Opinion from the Committee for Orphan Medicinal Products in the European Union for Treatment of CML | April 20, 2010 | Pharma News - Business Wire |
| Swedish Orphan Nabs 10-Year Distribution Rights to Pharming’s HAE Therapy in Europe | April 15, 2010 | GEN News Highlights |
| Swedish Orphan Biovitrum and Pharming sign Rhucin(R) distribution agreement | April 15, 2010 | Marketwire - Pharma and Biotech |
| Orphan Drugs To Plug Pipeline Gaps | April 14, 2010 | Pharmaceutical - Moreover |
| Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry | April 08, 2010 | Pharmaceutical - Moreover |
| Swedish Orphan Biovitrum launches Willfact(R) under its distribution agreement with LFB BIOMEDICAMENTS | April 08, 2010 | Marketwire - Pharma and Biotech |
| Biovitrum (SE) - Swedish Orphan Biovitrum makes payment to vendors of Cambridge Biotechnology Limited | April 07, 2010 | Biotechnology - Moreover |
| Swedish Orphan Biovitrum makes payment to vendors of Cambridge Biotechnology Limited | April 06, 2010 | Biotechnology - Moreover |
| Frost & Sullivan: Orphan Drugs to Create Paradigm Shift in the Ph... | April 06, 2010 | Pharmaceutical - Moreover |
| Frost & Sullivan: Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry! | April 06, 2010 | Biotech News - PR Newswire |
| Swedish Orphan Biovitrum extends Cyanokit(R) cooperation with Merck Serono | April 01, 2010 | Marketwire - Pharma and Biotech |
| Orphan Drug Market Catches Pharma's Eye | March 27, 2010 | Pharmaceutical - Moreover |
| Diamyd Medical AB Granted Orphan Drug Designation in the US | March 23, 2010 | BioSpace - Breaking News |
| Diamyd Granted Orphan Drug Designation in the US | March 23, 2010 | FDA News - Business Wire |
| Diamyd Medical: Diamyd granted Orphan Drug Designation in the US | March 23, 2010 | Pharma News - Business Wire |
| BioSante Pharmaceuticals, Inc. Announces Additional Positive Leukemia Vaccine Results and Second FDA Orphan Drug Designation | March 23, 2010 | BioSpace - Breaking News |
| BioSante Announces Additional Positive Leukemia Vaccine Results and Second FDA Orphan Drug Designation | March 23, 2010 | FDA News - Business Wire |
| Swedish Orphan Biovitrum updates European Kepivance(R) label | March 23, 2010 | Marketwire - Pharma and Biotech |
| Carbaglu (carglumic acid"Orphan Pharmaceutical Company) approved for treating condition that causes elevated ammonia levels | March 19, 2010 | Pharmaceutical - Moreover |
| Allon Receives European Orphan Drug Status for Davunetide | March 17, 2010 | Marketwire - Pharma and Biotech |
| BioSante cancer vaccine gets 'orphan drug' status | March 15, 2010 | Health News - CNBC |
| BioSante Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer Vaccine | March 15, 2010 | BioSpace - Breaking News |
| BioSante Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer Vaccine | March 15, 2010 | FDA News - Business Wire |
| Swedish Orphan Biovitrum has agreed to an additional Kineret(R) drug campaign with Amgen | March 12, 2010 | Marketwire - Pharma and Biotech |
| Gehrig's disease drug from Cytokinetics wins orphan status | March 11, 2010 | Health News - BizJournals.com |
| Bayer’s Cipro CF Drug Gets Orphan Designation | March 11, 2010 | Contract Pharma |
| FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis | March 11, 2010 | Pharma News - PR Newswire |
| FDA Grants Orphan Status to Cytokinetics Treatment for Lou Gehrig’s Disease | March 10, 2010 | Biotechnology - Moreover |
| Cytokinetics, Inc. Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis | March 10, 2010 | BioSpace - Breaking News |
| Cytokinetics gets orphan drug status for ALS drug | March 10, 2010 | FierceBiotech |
| FDA grants Cytokinetics treatment orphan status | March 10, 2010 | Health News - CNBC |
| Cytokinetics, Inc.'s Lou Gehrig's Drug Gets Orphan Status | March 10, 2010 | BioSpace |
| NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis | March 10, 2010 | FDA News - Business Wire |
| Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis | March 10, 2010 | Marketwire - Pharma and Biotech |
| ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA and EU | March 09, 2010 | BioSpace - Breaking News |
| FDA Grants Orphan Drug Designation To ImmunoGen IMGN901 Compound | March 09, 2010 | Biotechnology - Moreover |
| ImmunoGen cancer drug gets 'orphan drug' status | March 08, 2010 | Health News - CNBC |
| ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA and EU COMP | March 08, 2010 | FDA News - Business Wire |
| ImmuneRegen BioSciences, Inc. Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fibrosis | March 04, 2010 | BioSpace - Breaking News |
| ImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fibrosis | March 04, 2010 | Marketwire - Pharma and Biotech |
| Research and Markets: Opportunities in Orphan Drugs: Strategies for Developing Maximum Returns from Niche Indications | March 04, 2010 | Pharma News - Business Wire |
| Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt???s Macular Dystrophy | March 02, 2010 | BioSpace - Breaking News |
| Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt’s Macular Dystrophy | March 02, 2010 | FDA News - Business Wire |
| AEterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for Perifosine for the Treatment of Multiple Myeloma from the Committee for Orphan Medicinal Products of the | March 01, 2010 | BioSpace |
| Ariad cancer treatment gets 'orphan drug' status | March 01, 2010 | Health News - CNBC |
| Æterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for Perifosine for the Treatment of Multiple Myeloma from the Committee for Orphan Medicinal Products of the European Medicines Agency | March 01, 2010 | Biotech News - PR Newswire |
| ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia | March 01, 2010 | Pharma News - Business Wire |
| International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report | February 27, 2010 | Medical Pharma - PR Newswire |
| Research and Markets: Orphan Drugs in Asia 2010: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market | February 26, 2010 | Pharma News - Business Wire |
| Lithera Obtains Orphan Drug Product Designation for LIPO-102 | February 23, 2010 | Pharmaceutical - Moreover |
| New Report Analyzes the Future of Orphan Disease Therapeutics | February 23, 2010 | Marketwire - Pharma and Biotech |
| Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement | February 18, 2010 | BioSpace |
| Reportlinker Adds Opportunities in Orphan Drugs: Strategies for Developing Maximum Returns From Niche Indications | February 18, 2010 | Medical Pharma - PR Newswire |
| Biogen Idec Takes Over Development of Hemophilia Therapies in Deal with Swedish Orphan Biovitrum | February 18, 2010 | GEN News Highlights |
| Karolinska Development AB: European Medicines Evaluation Agency Recommends Orphan Drug Designation for Acute Myeloid Leukemia Treatment | February 18, 2010 | BioSpace - Breaking News |
| Karolinska Development: EMEA Recommends Orphan Drug Designation for Acute Myeloid Leukemia Treatment | February 18, 2010 | Pharma News - PR Newswire |
| Samenvatting: Biogen Idec en Swedish Orphan Biovitrum werken hun hemofiliesamenwerking bij | February 18, 2010 | Pharma News - Business Wire |
| Resumen: Biogen Idec y Swedish Orphan Biovitrum modifican acuerdo de alianza en relación con la hemofilia | February 18, 2010 | Pharma News - Business Wire |
| Biogen Idec et Swedish Orphan Biovitrum modifient leur accord de partenariat concernant l'hémophilie | February 18, 2010 | Pharma News - Business Wire |
| Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement | February 18, 2010 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Swedish Orphan Biovitrum aggiornano l'accordo di partnership per l'emofilia | February 18, 2010 | Pharma News - Business Wire |
| Biogen Idec und Swedish Orphan Biovitrum ändern Partnerschaftsvertrag für Hämophilieprojekt | February 18, 2010 | Pharma News - Business Wire |
| Quark drug wins orphan status from FDA | February 16, 2010 | Health News - BizJournals.com |
| Reportlinker Adds Orphan Drugs in Asia 2010: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market | February 16, 2010 | Pharma News - PR Newswire |
| EntreMed, Inc. Receives Orphan Drug Designation for ENMD-2076 in Leukemia | February 16, 2010 | BioSpace - Breaking News |
| EntreMed Receives Orphan Drug Designation for ENMD-2076 in Leukemia | February 16, 2010 | Pharma News - PR Newswire |
| Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access | February 09, 2010 | Pharma News - Business Wire |
| Talecris Drug Gains Orphan Designation | February 08, 2010 | Contract Pharma |
| Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division | February 08, 2010 | Medical Pharma - PR Newswire |
| Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin Deficiency | February 05, 2010 | Pharma News - Business Wire |
| AVI BioPharma, Inc.'s Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy | February 05, 2010 | BioSpace |
| AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy | February 05, 2010 | Marketwire - Pharma and Biotech |
| ERYtech Pharma obtains FDA orphan drug designation for leukemia drug | January 28, 2010 | Biotechnology - Moreover |
| Erytech leukemia drug Graspa gets orphan status | January 27, 2010 | Health News - BizJournals.com |
| EpiCept Receives Orphan Drug Designation for EpiCept™ NP-1 in U.S. | January 27, 2010 | FDA News - Business Wire |
| Biogen Idec, Orphan Biovitrum partner for hemophilia B drug trial | January 26, 2010 | Biotechnology - Moreover |
| ERYtech Pharma: FDA Grants Orphan Drug Designation to GRASPA® for Treatment of Acute Lymphoblastic Leukaemia | January 26, 2010 | Pharma News - Business Wire |
| Resumen: Biogen Idec y Swedish Orphan Biovitrum anuncian la administración de dosis al primer paciente a través de un ensayo mundial y de registro para el tratamiento de la hemofilia B de acción prolongada | January 25, 2010 | Pharma News - Business Wire |
| Samenvatting: Biogen Idec en het Swedish Orphan Biovitrum maken bekend dat de eerste patiënt zijn dosis heeft ontvangen in de hemofilie-B test | January 25, 2010 | Pharma News - Business Wire |
| Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapy | January 25, 2010 | Clinical Trials - Business Wire |
| Riassunto: Biogen Idec e Swedish Orphan Biovitrum annunciano la somministrazione di dosi al primo paziente nella sperimentazione per la registrazione a livello internazionale della terapia ad azione protratta per l’emofilia | January 25, 2010 | Clinical Trials - Business Wire |
| Biogen Idec et Swedish Orphan Biovitrum annoncent le dosage réussi du premier patient dans le cadre d’un essai mondial d’homologation d’une thérapie à action prolongée pour l’hémophilie B | January 25, 2010 | Clinical Trials - Business Wire |
| Biogen Idec und Swedish Orphan Biovitrum melden die erste Patientenbehandlung mit ihrem langwirkenden Hämophilie-B-Medikament in globaler Zulassungsstudie | January 25, 2010 | Clinical Trials - Business Wire |
| U.S. Orphan Product Designations More Than Doubled During Last Decade, According to Tufts Center for the Study of Drug Development | January 20, 2010 | Marketwire - Pharma and Biotech |
| Octapharma AG Receives Orphan Drug Exclusivity Approval for wilate(R) | January 13, 2010 | BioSpace - Breaking News |
| Protalix Biotherapeutics's COMP Adopts Positive Opinion for the Orphan Drug Designation for Protalix Biotherapeutics's Taliglucerase Alfa | January 13, 2010 | BioSpace - Breaking News |
| European Medicines Agency's COMP Adopts Positive Opinion for the Orphan Drug Designation for Protalix's taliglucerase alfa | January 13, 2010 | Clinical Trials - PR Newswire |
| Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease | January 13, 2010 | Pharma News - PR Newswire |
| FDA Grants Orphan Drug Status to Allon Therapeutics, Inc.'s Davunetide for Brain Disease | January 12, 2010 | BioSpace - Breaking News |
| FDA Grants Orphan Drug Status to Allon's Davunetide for Brain Disease | January 12, 2010 | Marketwire - Pharma and Biotech |
| Clavis Pharma gets orphan drug status, new CEO | January 08, 2010 | FierceBiotech |
| FDA Grants Orphan Drug Status for Personalized Lymphoma Vaccine | January 07, 2010 | FDA News - Business Wire |
| Research and Markets: The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement | January 06, 2010 | Pharma News - Business Wire |
| FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010 | December 23, 2009 | Pharma News - PR Newswire |
| European Medicines Evaluation Agency Grants Cell Therapeutics, Inc. Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL) | December 21, 2009 | BioSpace - Breaking News |
| Cell Therapeutics, Inc. Says Cancer Drug Gets Orphan Status in Europe | December 21, 2009 | BioSpace |
| European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL) | December 21, 2009 | Biotech News - PR Newswire |
| Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement | December 15, 2009 | Biotech News - PR Newswire |
| Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease | December 09, 2009 | Biotech News - PR Newswire |
| BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment | December 08, 2009 | Clinical Trials - PR Newswire |
| Stem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan Drug Designation | | FDA News - Business Wire |
| LFB’s Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in Europe for Chronic Lymphocytic Leukemia | | Clinical Trials - Business Wire |
